Genomic Valley Biotech (BOM:539206) Total Liabilities : ₹0.00 Mil (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genomic Valley Biotech Total Liabilities?

Genomic Valley Biotech's Total Liabilities for the quarter that ended in Dec. 2024 was ₹0.00 Mil.

Genomic Valley Biotech's quarterly Total Liabilities increased from Jun. 2024 (₹0.00 Mil) to Sep. 2024 (₹3.44 Mil) but then declined from Sep. 2024 (₹3.44 Mil) to Dec. 2024 (₹0.00 Mil).

Genomic Valley Biotech's annual Total Liabilities declined from Mar. 2022 (₹9.19 Mil) to Mar. 2023 (₹8.94 Mil) and declined from Mar. 2023 (₹8.94 Mil) to Mar. 2024 (₹7.92 Mil).

Genomic Valley Biotech Total Liabilities Historical Data

The historical data trend for Genomic Valley Biotech's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Valley Biotech Total Liabilities Chart

Genomic Valley Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

29.59

31.30

9.19

8.94

7.92

Genomic Valley Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial															-	7.92	-	3.44	-

Genomic Valley Biotech Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genomic Valley Biotech's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.914	+	(0	+	0.0020000000000007
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	7.92

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	43.337	-	35.421
	=	7.92

Genomic Valley Biotech's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	N/A	-	N/A
	=	N/A

Genomic Valley Biotech Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genomic Valley Biotech's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomic Valley Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomic Valley Biotech Ltd (BOM:539206) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 K.M. Stone, Berri Charra Road, P.O. Tandaheri, Tehsil-Bahadurgarh, Village Kherka Musalman, Jhajjar, HR, IND, 124507

Website

http://www.genomicvalley.com

Genomic Valley Biotech Ltd is an India-based company engaged in providing diagnostic services and related business services. It undertakes commercial production of plant tissue cultured plants of different species to feed the genetically improved plant market nationally as well as internationally. The group conducts research in the field of agriculture, plant tissue culture, medical biotechnology, SERI biotechnology, stem cell, food biotechnology, Drone technology, Poly House Construction, and others. It generates revenue from the sale of services.

Genomic Valley Biotech Headlines

No Headlines